140 related articles for article (PubMed ID: 31033235)
1. HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma.
Ge Z; Tian T; Meng L; Song C; Yu C; Xu X; Liu J; Dai J; Hu Z
Cancer Med; 2019 Jun; 8(6):3086-3093. PubMed ID: 31033235
[TBL] [Abstract][Full Text] [Related]
2. Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.
Khan A; Al Balwi MA; Tanaka Y; Hajeer A; Sanai FM; Al Abdulkarim I; Al Ayyar L; Badri M; Saudi D; Tamimi W; Mizokami M; Al Knawy B
Int J Cancer; 2013 Dec; 133(12):2864-71. PubMed ID: 23740667
[TBL] [Abstract][Full Text] [Related]
3. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon.
Atsama Amougou M; Marchio A; Bivigou-Mboumba B; Noah Noah D; Banai R; Atangana PJA; Fewou Moundipa P; Pineau P; Njouom R
J Viral Hepat; 2019 Sep; 26(9):1086-1093. PubMed ID: 31106515
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.
Asim M; Malik A; Sarma MP; Polipalli SK; Begum N; Ahmad I; Khan LA; Husain SA; Akhtar N; Husain S; Thayumanavan L; Singla R; Kar P
J Med Virol; 2010 Jul; 82(7):1115-25. PubMed ID: 20513073
[TBL] [Abstract][Full Text] [Related]
5. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
[TBL] [Abstract][Full Text] [Related]
6. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma.
Song C; Liu Y; Xu L; Wen J; Jiang D; Chen J; Zhai X; Hu Z; Liu L; Liu J
Cancer Med; 2016 Jul; 5(7):1687-93. PubMed ID: 27075395
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter].
Tan YW; Zhang YH; Jiang WJ; Xing MY; Man XB; Mao JZ; Ge GH; Wu CS; Zhu MQ; Xu J; Sun L; Zhou XP
Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):679-83. PubMed ID: 24160343
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
[TBL] [Abstract][Full Text] [Related]
11. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma.
Mak D; Kramvis A
Arch Virol; 2020 Aug; 165(8):1815-1825. PubMed ID: 32504396
[TBL] [Abstract][Full Text] [Related]
13. An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People.
Hayashi S; Khan A; Simons BC; Homan C; Matsui T; Ogawa K; Kawashima K; Murakami S; Takahashi S; Isogawa M; Ikeo K; Mizokami M; McMahon BJ; Tanaka Y
Hepatology; 2019 Jan; 69(1):19-33. PubMed ID: 29893492
[TBL] [Abstract][Full Text] [Related]
14. Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.
Chen QY; Hu YL; Wang XY; Harrison TJ; Wang C; Hu LP; Yang QL; Ren CC; Jia HH; Fang AZ
Int J Med Sci; 2019; 16(7):990-997. PubMed ID: 31341412
[No Abstract] [Full Text] [Related]
15. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.
Tatsukawa M; Takaki A; Shiraha H; Koike K; Iwasaki Y; Kobashi H; Fujioka S; Sakaguchi K; Yamamoto K
BMC Cancer; 2011 Oct; 11():458. PubMed ID: 22014121
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
Thongbai C; Sa-nguanmoo P; Kranokpiruk P; Poovorawan K; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2013; 14(6):3555-9. PubMed ID: 23886144
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2.
Ryu HJ; Kim DY; Park JY; Chang HY; Lee MH; Han KH; Chon CY; Ahn SH
J Med Virol; 2011 Dec; 83(12):2088-95. PubMed ID: 22012715
[TBL] [Abstract][Full Text] [Related]
20. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
